Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

ACS, Almirall, Endesa, REN, Viscofan: Iberian Equity Preview

The following companies may have unusual price changes in Spanish and Portuguese trading. Stock symbols are in parentheses and share prices are from the previous close.

Spain’s IBEX 35 Index fell 2 percent to 10,396.30. Portugal’s PSI-20 Index lost 0.6 percent to 7,768.53.

Spanish stocks:

Actividades de Construccion y Servicios SA (ACS SM): Spain’s biggest construction company is due to report first-quarter earnings after the market closes. The shares lost 1.3 percent to 32.90 euros.

Almirall SA (ALM SM): The Barcelona-based pharmaceutical company said its Actikerall dermatological treatment was recommended for approval in seven European countries including Germany, the U.K., Poland and Austria. The company is scheduled to report first-quarter earnings. The stock gained 1.1 percent to 7.98 euros.

Endesa SA (ELE SM): The Spanish power company controlled by Enel SpA is due to report earnings before the market opens. The stock lost 2.2 percent to 22.95 euros.

Viscofan SA (VIS SM): The Spanish sausage-casing maker is scheduled to report first-quarter earnings after the market closes. The shares lost 2.7 percent to 29.72 euros.

Portuguese stocks:

REN-Redes Energeticas Nacionais SA (RENE PL): The operator of Portugal’s electricity and gas networks said first-quarter net income rose 37 percent to 34.4 million euros. The stock lost 0.6 percent to close at 2.45 euros before the earnings announcement.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.